Imaging and quantification of corneal neovascularization

被引:5
作者
Benayoun, Y. [1 ,2 ]
Rosenberg, R. [3 ]
Casse, G. [4 ]
Dallaudiere, B. [5 ]
Robert, P-Y [1 ]
机构
[1] CHU Limoges, Hop Dupuytren, Serv Ophtalmol, F-87042 Limoges 1, France
[2] Clin Francois Chenieux, Serv Ophtalmol, F-87039 Limoges, France
[3] CHRU Lille, Hop Huriez, Serv Ophtalmol, F-59037 Lille, France
[4] Clin Pasteur, F-31300 Toulouse, France
[5] Hop Bichat Claude Bernard, Serv Radiol, F-75877 Paris 18, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2013年 / 36卷 / 08期
关键词
Corneal neovascularization; Angiogenesis; Corneal transplants; VIVO CONFOCAL MICROSCOPY; CONTACT-LENS COMPLICATIONS; INDOCYANINE GREEN ANGIOGRAPHY; HIGH-RISK KERATOPLASTY; IN-VIVO; SUBCONJUNCTIVAL BEVACIZUMAB; PENETRATING KERATOPLASTY; TOPICAL BEVACIZUMAB; GRADING SCALES; PHOTODYNAMIC THERAPY;
D O I
10.1016/j.jfo.2013.04.006
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Corneal neovascularization is defined as the invasion of vessels into the normally avascular clear corneal stroma, secondary to acute or chronic tissue injury. In addition to decreasing visual acuity, vascularity introduces circulating immune cells, reducing corneal immune privilege and the graft survival of subsequent keratoplasty. Thus, reducing neovascularization has become a recent therapeutic target in order to increase the success of corneal transplantation. Comparing the effects of antiangiogenic drugs assumes that we are able to quantify corneal neovascularization before and after treatment. In the first part of this literature review, we present the various methods to document neovessels (color photos, fluorescein and indocyanine green anterior segment angiography, in vivo confocal microscopy). Next, we report methods to classify and quantify corneal neovascularization. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:693 / 703
页数:11
相关论文
共 72 条
  • [1] Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease
    Altenburger, Amadeus E.
    Bachmann, Bjoern
    Seitz, Berthold
    Cursiefen, Claus
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (11) : 1663 - 1671
  • [2] Imaging and Evaluation of Corneal Vascularization Using Fluorescein and Indocyanine Green Angiography
    Anijeet, Deepa R.
    Zheng, Yalin
    Tey, Adrian
    Hodson, Martin
    Sueke, Henri
    Kaye, Stephen B.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (02) : 650 - 658
  • [3] AURAN JD, 1995, OPHTHALMOLOGY, V102, P33
  • [4] Subconjunctival bevacizumab for vascularized rejected corneal grafts
    Awadein, Ahmed
    [J]. JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (11) : 1991 - 1993
  • [5] Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264
  • [6] Subconjunctival bevacizumab lnjection for corneal neovascularization
    Bahar, Irit
    Kaiserman, Igor
    McAllum, Penny
    Rootman, David
    Slomovic, Allan
    [J]. CORNEA, 2008, 27 (02) : 142 - 147
  • [7] The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
    Barros, Luiz F. M.
    Belfort, Rubens, Jr.
    [J]. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2007, 79 (03): : 389 - 394
  • [8] Effects of Subconjunctival Bevacizumab on Corneal Neovascularization: Results of a Prospective Study
    Benayoun, Yohan
    Adenis, Jean-Paul
    Casse, Guillaume
    Forte, Raimondo
    Robert, Pierre-Yves
    [J]. CORNEA, 2012, 31 (08) : 937 - 944
  • [9] Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts
    Bock, F.
    Onderka, J.
    Hos, D.
    Horn, F.
    Martus, P.
    Cursiefen, C.
    [J]. EXPERIMENTAL EYE RESEARCH, 2008, 87 (05) : 462 - 470
  • [10] Bevacizumab (Avastin) eye drops inhibit corneal neovascularization
    Bock, Felix
    Koenig, Yanyan
    Kruse, Friedrich
    Baier, Martin
    Cursiefen, Claus
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (02) : 281 - 284